Literature DB >> 17188378

The emerging anti-inflammatory role of HDL-cholesterol, illustrated in cardiovascular disease free population; the ATTICA study.

Christina Chrysohoou1, Christos Pitsavos, John Skoumas, Constantina Masoura, Anastasia Katinioti, Demosthenes Panagiotakos, Christodoulos Stefanadis.   

Abstract

OBJECTIVE: In this work we assessed the relationship between HDL-cholesterol levels and various inflammation markers status in a sample of cardiovascular disease free adult men and women from Greece.
METHODS: The ATTICA study is a population-based cohort that has randomly enrolled 1128 men and 1154 women (aged >18 years old), stratified by age-gender, from the greater area of Athens, during 2001-2002. Adherence to Mediterranean diet was assessed through a diet-score that was based on a validated food-frequency questionnaire. In this study we assessed the relationship between HDL-cholesterol levels and inflammation markers (high sensitivity C-reactive protein, interleukin-6, homocysteine and amyloid-a), after taking into account the effect of several confounders.
RESULTS: 46% of men and 40% of women had total serum cholesterol levels >200 mg/dl, while 21% of men and 7% of women had HDL-cholesterol levels <35 mg/dl. The mean value for HDL-cholesterol was 53+/-14 mg/dl in females and 44+/-14 mg/dl in males. HDL-cholesterol levels were inversely correlated to the hs-CRP levels (b=-0.028, P=0.001) and homocysteine levels (b=-0.039, P=0.036), after adjustment for sex, age, body mass index, physical activity status, smoking, total cholesterol levels, lipid lower agents, ethanol intake and diabetes mellitus; while no statistical significance was found between HDL-cholesterol levels and interleukin-6 and serum amyloid-a.
CONCLUSIONS: In this work we evaluated the inverse relationship between HDL-cholesterol levels and inflammatory markers in a sample adult cardiovascular disease free population. This study among others illustrates the anti-inflammatory emerging role of HDL-cholesterol in reducing cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188378     DOI: 10.1016/j.ijcard.2006.11.010

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

Review 1.  Migraine and metabolism.

Authors:  G Casucci; V Villani; D Cologno; F D'Onofrio
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

2.  Association Between Low-Grade Systemic Inflammation and Type 2 Diabetes Mellitus Among Men and Women from the ATTICA Study.

Authors:  Christos Pitsavos; Metaxia Tampourlou; Demosthenes B Panagiotakos; Yannis Skoumas; Christina Chrysohoou; Tzortzis Nomikos; Christodoulos Stefanadis
Journal:  Rev Diabet Stud       Date:  2007-08-10

Review 3.  Biological activities of phenolic compounds present in virgin olive oil.

Authors:  Sara Cicerale; Lisa Lucas; Russell Keast
Journal:  Int J Mol Sci       Date:  2010-02-02       Impact factor: 5.923

Review 4.  Putative mechanisms of the relationship between obesity and migraine progression.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2008-06

5.  A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.

Authors:  P Matafome; E Nunes; T Louro; C Amaral; J Crisóstomo; L Rodrigues; A R Moedas; P Monteiro; A Cipriano; R Seiça
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-21       Impact factor: 3.000

6.  Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients.

Authors:  Anita Trauninger; Eszter Leél-Ossy; David Olayinka Kamson; László Pótó; Mihály Aradi; Ferenc Kövér; Marianna Imre; Hedvig Komáromy; Szilvia Erdélyi-Botor; Agnes Patzkó; Zoltán Pfund
Journal:  J Headache Pain       Date:  2011-02-18       Impact factor: 7.277

7.  Dietary, anthropometric, and biochemical determinants of plasma high-density lipoprotein-cholesterol in free-living adults.

Authors:  Erick Prado de Oliveira; Rodrigo Minoru Manda; Gabriel Augusto Torezan; José Eduardo Corrente; Roberto Carlos Burini
Journal:  Cholesterol       Date:  2010-12-15

8.  Markers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without Diabetes.

Authors:  Giuseppina T Russo; Annalisa Giandalia; Elisabetta L Romeo; Angela Alibrandi; Katalin V Horvath; Bela F Asztalos; Domenico Cucinotta
Journal:  Int J Endocrinol       Date:  2014-09-02       Impact factor: 3.257

9.  Association of Elevated Levels of Inflammatory Marker High-Sensitivity C-Reactive Protein and Hypertension.

Authors:  Sharmila Bisaria; Vittorio Terrigno; Krystal Hunter; Satyajeet Roy
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

Review 10.  The Role of High-Density Lipoprotein Cholesterol in 2022.

Authors:  Cesare R Sirtori; Alberto Corsini; Massimiliano Ruscica
Journal:  Curr Atheroscler Rep       Date:  2022-03-10       Impact factor: 5.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.